PubRank

R G Fariello

Author PubWeight™ 40.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Familial and acquired paroxysmal dyskinesias. A proposed classification with delineation of clinical features. Arch Neurol 1978 1.45
2 Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurosci 1988 1.12
3 Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. Mol Pathol 2001 1.09
4 Safinamide: from molecular targets to a new anti-Parkinson drug. Neurology 2006 1.09
5 A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease. Neurology 2006 1.07
6 EEG in phenylketonuria. Attempt to establish clinical importance of EEG changes. Arch Neurol 1981 1.01
7 Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition. Neurology 2006 1.01
8 Studies on lipid peroxidation in the rat brain. Neurochem Res 1994 0.98
9 Synthesis and anticonvulsant activity of a new class of 2-[(arylalky)amino]alkanamide derivatives. J Med Chem 1998 0.95
10 C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction. Exp Gerontol 2012 0.94
11 Eating epilepsy associated with a deep forebrain glioma. Ann Neurol 1979 0.93
12 Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins. J Neurochem 2000 0.92
13 Hyperekplexia exacerbated by occlusion of posterior thalamic arteries. Arch Neurol 1983 0.92
14 Improvement of motor function in early Parkinson disease by safinamide. Neurology 2004 0.91
15 EEG recognition of Aicardi's syndrome. Arch Neurol 1977 0.91
16 Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research). J Nutr Health Aging 2011 0.91
17 Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J Neurosci Res 2002 0.89
18 The THIP-induced model of bilateral synchronous spike and wave in rodents. Neuropharmacology 1987 0.88
19 Neuroradiological correlates of frontally predominant intermittent rhythmic delta activity (FIRDA). Electroencephalogr Clin Neurophysiol 1982 0.87
20 Biochemical and electrophysiological studies on the mechanism of action of PNU-151774E, a novel antiepileptic compound. J Pharmacol Exp Ther 1999 0.87
21 Sodium channel activity and sigma binding of 2-aminopropanamide anticonvulsants. Bioorg Med Chem Lett 1999 0.85
22 Epileptogenic action of intraventricularly injected antimelatonin antibody. Neurology 1977 0.84
23 Letter: Treatment of hiccup. Lancet 1974 0.84
24 Neuromelanic pigment in substantia nigra neurons of rats and dogs. Neurosci Lett 1986 0.83
25 PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat. Eur J Pharmacol 1998 0.83
26 Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse. Neuropharmacology 1986 0.82
27 The prepiriform cortex in dementia of the Alzheimer type. Arch Neurol 1987 0.81
28 Anti-allodynic effect of NW-1029, a novel Na(+) channel blocker, in experimental animal models of inflammatory and neuropathic pain. Pain 2003 0.80
29 Strain differences in convulsive response to the excitotoxin kainic acid. Neuroreport 1991 0.80
30 The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour. J Neural Transm Suppl 2003 0.80
31 Generalized cortical electrodecremental event. Clinical and neurophysiological observations in patients with dystonic seizures. Arch Neurol 1979 0.79
32 The uptake of carnitine by slices of rat cerebral cortex. J Neurochem 1981 0.79
33 The value of intraoperative EEG monitoring during carotid endarterectomy. Ann Neurol 1986 0.78
34 Delta9-tetrahydrocannabinol and epilepsy in the photosensitive baboon, Papio papio. Epilepsia 1974 0.78
35 The perspective of GABA replenishment therapy in the epilepsies: a critical evaluation of hopes and concerns. Life Sci 1983 0.78
36 Computer analysis of EEG activity in dementia of the Alzheimer's type and Huntington's disease. Neurobiol Aging 1990 0.78
37 FCE 23884, substrate-dependent interaction with the dopaminergic system. I. Preclinical behavioral studies. J Pharmacol Exp Ther 1991 0.77
38 Anticonvulsant activity of PNU-151774E in the amygdala kindled model of complex partial seizures. Epilepsia 1999 0.77
39 Regional distribution of malonaldehyde in mouse brain. Biochem Pharmacol 1988 0.77
40 Evidence for an epileptogenic action of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine. Neuropharmacology 1989 0.76
41 Homotaurine (3 aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effect of systemically administered kainic acid. Neurology 1982 0.76
42 Parenteral penicillin in rats: an experimental model of multifocal epilepsy. Epilepsia 1976 0.76
43 The distribution and role of carnitine in the mammalian brain. Life Sci 1982 0.76
44 Dopamine receptors status after unilateral nigral 6-OHDA lesion. Autoradiographic and in situ hybridization study in the rat brain. Mol Chem Neuropathol 1993 0.76
45 Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in Macaca fascicularis. Neurosci Lett 1989 0.76
46 L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia. Mov Disord 1990 0.76
47 FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies. J Pharmacol Exp Ther 1991 0.76
48 Limbic spindles: genuine cerebral activity or artifact? Electroencephalogr Clin Neurophysiol 1978 0.75
49 Penicillin spikes in rats. Limitations of a simple model for the study of anticonvulsants. Neuropharmacology 1984 0.75
50 Activating effects of homotaurine and taurine on corticoreticular epilepsy. Epilepsia 1981 0.75
51 Taurine and related amino acids in seizure disorders--current controversies. Prog Clin Biol Res 1985 0.75
52 Multiprocessing computer system for sensory evoked potentials and EEG spectral analysis for clinical neurophysiology laboratory. J Med Syst 1985 0.75
53 Ketamine activation of experimental corticoreticular epilepsy. Neurology 1980 0.75
54 Epileptogenic properties of enflurane and their clinical interpretation. Electroencephalogr Clin Neurophysiol 1980 0.75
55 Substantia nigra and pentylenetetrazol threshold in rats: correlation with striatal dopamine metabolism. Exp Neurol 1979 0.75
56 Pseudoperiodic bilateral EEG paroxysms in a case of phencyclidine intoxication. J Clin Psychiatry 1978 0.75
57 Diagnostic activation of epileptogenic foci by enflurane. Anesthesiology 1980 0.75
58 Transient seizure activity induced by acetylcarnitine. Neuropharmacology 1984 0.75
59 The epileptogenic action of 6-aminomethyl-3-methyl,1-4H-1,2,6-benzothiadiazine-1,1-diazide hydrochloride (TAG): non-specific versus specific antitaurine pathogenesis. Brain Res 1986 0.75
60 Amino acid profiles in Long-Evans rat superior colliculus, visual cortex, and inferior colliculus. Neurochem Res 1989 0.75
61 Changes in nitric oxide metabolite levels in stimulated substantia nigra neurons. Neuroreport 1997 0.75
62 Cortical and subcortical projected foci in cats: inhibitory action of taurine. Neurology 1975 0.75
63 Tetrodotoxin reveals action of spermine at presynaptic N-methyl-D-aspartate receptors. Eur J Pharmacol 1992 0.75
64 Neuropharmacological analysis of caudate-induced cortical inhibition. Funct Neurol 1987 0.75
65 Morphological and functional studies of rat tectal transplants. Brain Res Bull 1989 0.75
66 Age-related changes in the relative abundance of NMDAR1 mRNA spliced variants in the rat brain. Neuroreport 1994 0.75
67 Reenactment of the triggering situation for the diagnosis of epilepsy. Neurology 1983 0.75
68 Brainstem auditory evoked response in adrenoleukodystrophy. Ann Neurol 1979 0.75
69 Competitive inhibition by 3-aminopropanesulfonic acid and gamma-aminobutyric acid of carnitine transport in rat brain slices. Biochem Pharmacol 1981 0.75
70 Action of inhibitory amino acids on acute epileptic foci: an electrographic study. Exp Neurol 1979 0.75
71 Nitrite and nitrate levels in cerebrospinal fluid of normal subjects. J Neural Transm (Vienna) 1998 0.75